Form 8-K - Current report:
SEC Accession No. 0001437749-25-008869
Filing Date
2025-03-24
Accepted
2025-03-24 09:14:05
Documents
15
Period of Report
2025-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20240924_8k.htm   iXBRL 8-K 29232
2 EXHIBIT 99.1 ex_727055.htm EX-99.1 150754
  Complete submission text file 0001437749-25-008869.txt   352030

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250324.xsd EX-101.SCH 4114
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250324_def.xml EX-101.DEF 13522
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250324_lab.xml EX-101.LAB 17827
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250324_pre.xml EX-101.PRE 13499
17 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240924_8k_htm.xml XML 4967
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 25762547
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)